- Home
- LAES vs OLMA Comparison
LAES vs OLMA Comparison
Compare LAES & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- OLMA
- Stock Information
- Founded
- LAES 2022
- OLMA 2006
- Country
- LAES Switzerland
- OLMA United States
- Employees
- LAES N/A
- OLMA N/A
- Industry
- LAES Semiconductors
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- OLMA Health Care
- Exchange
- LAES Nasdaq
- OLMA Nasdaq
- Market Cap
- LAES 304.2M
- OLMA 289.0M
- IPO Year
- LAES N/A
- OLMA 2020
- Fundamental
- Price
- LAES $2.44
- OLMA $4.66
- Analyst Decision
- LAES Strong Buy
- OLMA Strong Buy
- Analyst Count
- LAES 1
- OLMA 3
- Target Price
- LAES $6.00
- OLMA $27.67
- AVG Volume (30 Days)
- LAES 4.5M
- OLMA 843.2K
- Earning Date
- LAES 05-20-2025
- OLMA 05-16-2025
- Dividend Yield
- LAES N/A
- OLMA N/A
- EPS Growth
- LAES N/A
- OLMA N/A
- EPS
- LAES N/A
- OLMA N/A
- Revenue
- LAES $10,981,000.00
- OLMA N/A
- Revenue This Year
- LAES N/A
- OLMA N/A
- Revenue Next Year
- LAES N/A
- OLMA N/A
- P/E Ratio
- LAES N/A
- OLMA N/A
- Revenue Growth
- LAES N/A
- OLMA N/A
- 52 Week Low
- LAES $0.29
- OLMA $2.86
- 52 Week High
- LAES $11.00
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- LAES 45.54
- OLMA 49.16
- Support Level
- LAES $2.33
- OLMA $4.35
- Resistance Level
- LAES $2.57
- OLMA $4.96
- Average True Range (ATR)
- LAES 0.20
- OLMA 0.39
- MACD
- LAES 0.00
- OLMA -0.07
- Stochastic Oscillator
- LAES 28.47
- OLMA 18.71
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.